The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ
Open accessAbstract
The p110 isoforms of phosphoinositide 3-kinase (PI3K) are acutely regulated by extracellular stimuli. The class IA PI3K catalytic subunits (p110α, p110β, and p110δ) occur in complex with a Src homology 2 (SH2) domain-containing p85 regulatory subunit, which has been shown to link p110α and p110δ to Tyr kinase signaling pathways. The p84/p101 regulatory subunits of the p110γ class IB PI3K lack SH2 domains and instead couple p110γ to G protein-coupled receptors (GPCRs). Here, we show, using small-molecule inhibitors with selectivity for p110β and cells derived from a p110β-deficient mouse line, that p110β is not a major effector of Tyr kinase signaling but couples to GPCRs. In macrophages, both p110β and p110γ contributed to Akt activation induced by the GPCR agonist complement 5a, but not by the Tyr kinase ligand colony-stimulating factor-1. In fibroblasts, which express p110β but not p110γ, p110β mediated Akt activation by the GPCR ligands stromal cell-derived factor, sphingosine-1-phosphate, and lysophosphatidic acid but not by the Tyr kinase ligands PDGF, insulin, and insulin-like growth factor 1. Introduction of p110γ in these cells reduced the contribution of p110β to GPCR signaling. Taken together, these data show that p110β and p110γ can couple redundantly to the same GPCR agonists. p110β, which shows a much broader tissue distribution than the leukocyte-restricted p110γ, could thus provide a conduit for GPCR-linked PI3K signaling in the many cell types where p110γ expression is low or absent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in Inflammation
Hirsch, E., Katanaev, V. L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., & Wymann, M. P. (2000) · Science · doi:10.1126/science.287.5455.1049 · Cited by 1,209
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
Knight, Z. A., Gonzalez, B., Feldman, M. E., Zunder, E. R., Goldenberg, D. D., Williams, O., Loewith, R., Stokoe, D., Balla, A., Toth, B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.035 · Cited by 1,174
Function of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A. J., Stanford, W. L., Bolon, B., Wakeham, A., Itie, A., Bouchard, D., Kozieradzki, I., et al. (2000) · Science · doi:10.1126/science.287.5455.1040 · Cited by 1,031
Phosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954
Self-citationImpaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice
Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S. E., Salpekar, A., Waterfield, M. D., et al. (2002) · Science · doi:10.1126/science.1073560 · Cited by 946
Self-citationBlockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis
Camps, M., Rückle, T., Ji, H., Ardissone, V., Rintelen, F., Shaw, J., Ferrandi, C., Chabert, C., Gillieron, C., Françon, B., et al. (2005) · Nature Medicine · doi:10.1038/nm1284 · Cited by 750
PI 3-kinase p110β: a new target for antithrombotic therapy
Jackson, S. P., Schoenwaelder, S. M., Goncalves, I., Nesbitt, W. S., Yap, C. L., Wright, C. E., Kenche, V., Anderson, K. E., Dopheide, S. M., Yuan, Y., et al. (2005) · Nature Medicine · doi:10.1038/nm1232 · Cited by 580
Phosphatidylinositol-3-OH kinases are Rab5 effectors
Christoforidis, S., Miaczynska, M., Ashman, K., Wilm, M., Zhao, L., Yip, S.-C., Waterfield, M. D., Backer, J. M., & Zerial, M. (1999) · Nature Cell Biology · doi:10.1038/12075 · Cited by 559
Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S. D., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.017 · Cited by 468
Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
Foukas, L. C., Claret, M., Pearce, W., Okkenhaug, K., Meek, S., Peskett, E., Sancho, S., Smith, A. J. H., Withers, D. J., & Vanhaesebroeck, B. (2006) · Nature · doi:10.1038/nature04694 · Cited by 463 · cited 2×
“Key differences between p110 and p110 in insulin signaling include selective recruitment of p110 over p110 to IRS-1/2 complexes (20) and the lack of p110 lipid kinase activity in these complexes (20, 21).”
BackgroundResultSelf-citationEarly embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase
Bi, L., Okabe, I., Bernard, D. J., & Nussbaum, R. L. (2002) · Mammalian Genome · doi:10.1007/bf02684023 · Cited by 318
Rapid generation of inducible mouse mutants
Seibler, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng012 · Cited by 305
Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function
Laffargue, M., Calvez, R., Finan, P., Trifilieff, A., Barbier, M., Altruda, F., Hirsch, E., & Wymann, M. P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00282-0 · Cited by 286
Kurosu, H., Maehama, T., Okada, T., Yamamoto, T., Hoshino, S.-I., Fukui, Y., Ui, M., Hazeki, O., & Katada, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24252 · Cited by 260
Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages
Vanhaesebroeck, B., Jones, G. E., Allen, W. E., Zicha, D., Hooshmand-Rad, R., Sawyer, C., Wells, C., Waterfield, M. D., & Ridley, A. J. (1999) · Nature Cell Biology · doi:10.1038/9045 · Cited by 236
Self-citationClass IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers
Geering, B., Cutillas, P. R., Nock, G., Gharbi, S. I., & Vanhaesebroeck, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700373104 · Cited by 225
Self-citationNot so strange bedfellows: G-protein-coupled receptors and Src family kinases
Luttrell, D. K., & Luttrell, L. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208162 · Cited by 221
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
Chaussade, C., Rewcastle, G. W., Kendall, J. D., Denny, W. A., Cho, K., Grønning, L. M., Chong, M. L., Anagnostou, S. H., Jackson, S. P., Daniele, N., et al. (2007) · Biochemical Journal · doi:10.1042/bj20070003 · Cited by 221
Maier, U., Babich, A., & Nürnberg, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29311 · Cited by 218
Brachmann, S. M., Ueki, K., Engelman, J. A., Kahn, R. C., & Cantley, L. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1596-1607.2005 · Cited by 179
The p110δ isoform of PI 3‐kinase negatively controls RhoA and PTEN
Papakonstanti, E. A., Ridley, A. J., & Vanhaesebroeck, B. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601763 · Cited by 152
Self-citationRoche, S., Downward, J., Raynal, P., & Courtneidge, S. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7119 · Cited by 137
Ali, K., Camps, M., Pearce, W. P., Ji, H., Rückle, T., Kuehn, N., Pasquali, C., Chabert, C., Rommel, C., & Vanhaesebroeck, B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2538 · Cited by 125
Self-citationRequirement for PI 3-kinase γ in macrophage migration to MCP-1 and CSF-1
Jones, G. E., Prigmore, E., Calvez, R., Hogan, C., Dunn, G., Hirsch, E., Wymann, M. P., & Ridley, A. J. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00318-5 · Cited by 117
Park, C. S., Schneider, I. C., & Haugh, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304968200 · Cited by 115
Leverrier, Y., Okkenhaug, K., Sawyer, C., Bilancio, A., Vanhaesebroeck, B., & Ridley, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306649200 · Cited by 105
Self-citationGraneß, A., Adomeit, A., Heinze, R., Wetzker, R., & Liebmann, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32016 · Cited by 87
Yart, A., Roche, S., Wetzker, R., Laffargue, M., Tonks, N. K., Mayeux, P., Chap, H., & Raynal, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110411200 · Cited by 86
Tang, X., & Downes, C. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14193 · Cited by 82
Hooshmand-Rad, R., Hájková, L., Klint, P., Karlsson, R., Vanhaesebroeck, B., Claesson, L., & Heldin, C. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.2.207 · Cited by 79
Self-citationHill, K. M., Welti, S., Yu, J., Murray, J. T., Yip, S.-C., Condeelis, J. S., Segall, J. E., & Backer, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3741 · Cited by 79
Meier, T. I., Cook, J. A., Thomas, J. E., Radding, J. A., Horn, C. L., Lingaraj, T., & Smith, M. C. (2004) · Protein Expression and Purification · doi:10.1016/j.pep.2003.12.010 · Cited by 48
Smith, A. J., Surviladze, Z., Gaudet, E. A., Backer, J. M., Mitchell, C. A., & Wilson, B. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100417200 · Cited by 47
Self-citationSpecific role for p85/p110β in GTP-binding-protein-mediated activation of Akt
Kubo, H., Hazeki, K., Takasuga, S., & Hazeki, O. (2005) · Biochemical Journal · doi:10.1042/bj20050671 · Cited by 40
Meier, T. I., Cook, J. A., Thomas, J. E., Radding, J. A., Horn, C. L., Lingaraj, T., & Smith, M. C. (2004) · Cancer Research · Cited by 14
Cited by
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
“, and there is evidence that p110β and p110γ are also activated by GPCRs through this route in intact cell”
BackgroundSelf-citationPhosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Thorpe, L. M., Yuzugullu, H., & Zhao, J. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3860 · Cited by 1,345
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Vergadi, E., Ieronymaki, E., Lyroni, K., Vaporidi, K., & Tsatsanis, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601515 · Cited by 1,148
Metadata
- Authors
- Guillermet-Guibert, J., Bjorklof, K., Salpekar, A., Gonella, C., Ramadani, F., Bilancio, A., Meek, S., Smith, A. J. H., Okkenhaug, K., & Vanhaesebroeck, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-06-17
- Volume
- 105
- Issue
- 24
- Pages
- 8292-8297
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2100458159
- Cited by
- 345
- References
- 35
- FWCI
- 15.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.